Orchestra BioMed Holdings (OBIO) Amortizatization of Intangibles (2022 - 2026)
Orchestra BioMed Holdings (OBIO) reported Amortizatization of Intangibles of $77000.0 for Q1 2026, down 47.62% year-over-year from $147000.0 in Q1 2025, and down 50.96% on a QoQ basis from $157000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) has 5 years of Amortizatization of Intangibles data on file, last reported at $77000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 47.62% year-over-year to $77000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $537000.0 (down 66.31% YoY) and the FY2025 annual result came in at $607000.0, down 59.56% from the prior year.
- Amortizatization of Intangibles eased to $77000.0 in Q1 2026 per OBIO's latest filing, from $157000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3.3 million in Q4 2023 and bottomed at -$1.6 million in Q3 2023.
- The 5-year median for Amortizatization of Intangibles is $153000.0 (2025), against an average of $388470.6.
- Peak annual rise in Amortizatization of Intangibles reached 1748.62% in 2023, while the deepest fall reached 1196.67% in 2023.
- Tracing OBIO's Amortizatization of Intangibles over 5 years: stood at $181000.0 in 2022, then surged by 1748.62% to $3.3 million in 2023, then slumped by 70.23% to $996000.0 in 2024, then sank by 84.24% to $157000.0 in 2025, then slumped by 50.96% to $77000.0 in 2026.
- Per Business Quant, the three latest OBIO Amortizatization of Intangibles figures stand at $77000.0 (Q1 2026), $157000.0 (Q4 2025), and $153000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Orchestra BioMed Holdings | 245.24 Mn | 255.02 Mn | 78,000.00 | 77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,000.00 |
| Mar 31, 2026 | 77,000.00 |
| Dec 31, 2025 | 157,000.00 |
| Dec 31, 2025 | 157,000.00 |
| Sep 30, 2025 | 153,000.00 |
| Sep 30, 2025 | 153,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | 996,000.00 |
| Dec 31, 2024 | 996,000.00 |
| Sep 30, 2024 | 281,000.00 |
| Sep 30, 2024 | 281,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 3.35 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | -1.65 Mn |
| Sep 30, 2023 | -1.65 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 155,000.00 |
| Mar 31, 2023 | 155,000.00 |
| Dec 31, 2022 | 181,000.00 |
| Dec 31, 2022 | 181,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 137,000.00 |
| Jun 30, 2022 | 137,000.00 |
| Mar 31, 2022 | 132,000.00 |
| Mar 31, 2022 | 132,000.00 |